 Applied Genetic Technologies Corporation is a mid-clinical-stage biotechnology company developing genetic therapies for rare and debilitating diseases. AGTCs initial focus is on ophthalmology study of medical conditions relating to the eye where AGTC has active programs for X-linked retinitis pigmentosa, achromatopsia, and optogenetics. 